Jilin Jian Yisheng Pharmaceutical Co Ltd Financial Flexibility Index
Jilin Jian Yisheng Pharmaceutical Co Ltd financial flexibility index. Jilin Jian Yisheng Pharmaceutical Co Ltd (002566) has a Financial Flexibility Index of 0.02x as of September 2025. Free cash flow of CN¥12.37 Million (operating CF CN¥8.20 Million minus capex CN¥4.18 Million) represents 0% of total liabilities (CN¥658.86 Million). Explore Jilin Jian Yisheng Pharmaceutical Co Ltd capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Jilin Jian Yisheng Pharmaceutical Co Ltd (2006–2025)
Financial flexibility index of Jilin Jian Yisheng Pharmaceutical Co Ltd from 2006 to 2025. Historical Financial Flexibility Index trend for Jilin Jian Yisheng Pharmaceutical Co Ltd across 20 annual periods. Check 002566 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Jilin Jian Yisheng Pharmaceutical Co Ltd Financial Flexibility Index by Year (2006–2025)
Jilin Jian Yisheng Pharmaceutical Co Ltd financial flexibility index by year from 2006 to 2025. Year-by-year free cash flow to debt coverage for Jilin Jian Yisheng Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see Jilin Jian Yisheng Pharmaceutical Co Ltd operating cash flow efficiency.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.18x | CN¥112.38 Million | CN¥98.74 Million | CN¥630.35 Million | ▲ +51.7% |
| 2024 | 0.12x | CN¥74.89 Million | CN¥58.94 Million | CN¥637.22 Million | ▼ -65.7% |
| 2023 | 0.34x | CN¥244.90 Million | CN¥209.13 Million | CN¥714.30 Million | ▲ +31.3% |
| 2022 | 0.26x | CN¥187.22 Million | CN¥145.86 Million | CN¥717.18 Million | ▼ -46.0% |
| 2021 | 0.48x | CN¥322.17 Million | CN¥215.10 Million | CN¥666.08 Million | ▲ +14.9% |
| 2020 | 0.42x | CN¥279.45 Million | CN¥203.51 Million | CN¥663.86 Million | ▼ -20.6% |
| 2019 | 0.53x | CN¥232.57 Million | CN¥210.87 Million | CN¥438.66 Million | ▲ +29.2% |
| 2018 | 0.41x | CN¥241.04 Million | CN¥167.32 Million | CN¥587.49 Million | ▼ -12.4% |
| 2017 | 0.47x | CN¥354.15 Million | CN¥270.65 Million | CN¥756.40 Million | ▲ +1004.0% |
| 2016 | 0.04x | CN¥36.88 Million | CN¥-17.52 Million | CN¥869.67 Million | ▲ +117.0% |
| 2015 | -0.25x | CN¥-222.04 Million | CN¥-324.29 Million | CN¥888.65 Million | ▲ +64.7% |
| 2014 | -0.71x | CN¥-523.57 Million | CN¥-592.06 Million | CN¥739.24 Million | ▼ -30.4% |
| 2013 | -0.54x | CN¥-116.10 Million | CN¥-188.45 Million | CN¥213.79 Million | ▼ -123.7% |
| 2012 | 2.29x | CN¥166.62 Million | CN¥79.08 Million | CN¥72.81 Million | ▲ +318.1% |
| 2011 | -1.05x | CN¥-67.69 Million | CN¥-112.12 Million | CN¥64.52 Million | ▼ -263.9% |
| 2010 | 0.64x | CN¥99.62 Million | CN¥50.73 Million | CN¥155.66 Million | ▼ -44.0% |
| 2009 | 1.14x | CN¥167.66 Million | CN¥125.25 Million | CN¥146.67 Million | ▲ +348.5% |
| 2008 | 0.25x | CN¥32.48 Million | CN¥20.50 Million | CN¥127.43 Million | ▼ -63.1% |
| 2007 | 0.69x | CN¥94.08 Million | CN¥82.66 Million | CN¥136.08 Million | ▲ +58.5% |
| 2006 | 0.44x | CN¥43.33 Million | CN¥25.58 Million | CN¥99.35 Million | — |